Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DB25FWZLW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,822
Award facts
- Contract value 100% obligated
- $7,821.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,821.66 to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. MONOVISC is a hyaluronic acid injection used for the treatment of osteoarthritis knee pain, indicating this procurement supports the Defense Health Agency's medical supply requirements for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a primary pharmaceutical vendor for federal military healthcare systems, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply a wide range of medications, medical devices, and specialized healthcare commodities to support military medical operations worldwide. The company's federal contract portfolio demonstrates its established capability to fulfill complex pharmaceutical procurement requirements across multiple therapeutic domains through competitively awarded agreements with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FWZLW?
SPE2DB25FWZLW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FWZLW worth?
The government has obligated $7,822 on SPE2DB25FWZLW.
Is contract SPE2DB25FWZLW an order under another contract?
Yes. SPE2DB25FWZLW is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWZLW competed?
The extent of competition for SPE2DB25FWZLW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award